A detailed history of Panagora Asset Management Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 152,162 shares of REGN stock, worth $119 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
152,162
Previous 170,758 10.89%
Holding current value
$119 Million
Previous $179 Million 10.87%
% of portfolio
0.78%
Previous 0.91%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1024.09 - $1201.76 $19 Million - $22.3 Million
-18,596 Reduced 10.89%
152,162 $160 Million
Q2 2024

Jul 29, 2024

BUY
$883.2 - $1071.19 $2.48 Million - $3 Million
2,803 Added 1.67%
170,758 $179 Million
Q1 2024

May 07, 2024

BUY
$902.69 - $993.35 $11.7 Million - $12.9 Million
12,997 Added 8.39%
167,955 $162 Million
Q4 2023

Feb 08, 2024

SELL
$775.18 - $881.7 $2.7 Million - $3.07 Million
-3,486 Reduced 2.2%
154,958 $136 Million
Q3 2023

Oct 31, 2023

BUY
$692.45 - $844.37 $1.64 Million - $2 Million
2,364 Added 1.51%
158,444 $130 Million
Q2 2023

Aug 11, 2023

BUY
$700.03 - $830.35 $6.07 Million - $7.2 Million
8,677 Added 5.89%
156,080 $112 Million
Q1 2023

May 11, 2023

BUY
$680.49 - $826.97 $11.1 Million - $13.5 Million
16,301 Added 12.43%
147,403 $121 Million
Q4 2022

Feb 13, 2023

SELL
$705.89 - $766.39 $24.6 Million - $26.7 Million
-34,854 Reduced 21.0%
131,102 $94.6 Million
Q3 2022

Nov 14, 2022

SELL
$573.97 - $724.32 $1.59 Million - $2.01 Million
-2,777 Reduced 1.65%
165,956 $114 Million
Q2 2022

Aug 15, 2022

SELL
$548.35 - $738.84 $3.11 Million - $4.19 Million
-5,670 Reduced 3.25%
168,733 $99.7 Million
Q1 2022

May 12, 2022

BUY
$595.12 - $698.43 $932,553 - $1.09 Million
1,567 Added 0.91%
174,403 $122 Million
Q4 2021

Feb 10, 2022

SELL
$543.48 - $670.97 $7.7 Million - $9.51 Million
-14,171 Reduced 7.58%
172,836 $109 Million
Q3 2021

Nov 10, 2021

BUY
$574.03 - $680.96 $14.3 Million - $17 Million
24,981 Added 15.42%
187,007 $113 Million
Q2 2021

Aug 11, 2021

BUY
$472.8 - $558.54 $6.95 Million - $8.21 Million
14,706 Added 9.98%
162,026 $90.5 Million
Q1 2021

May 12, 2021

BUY
$446.73 - $548.2 $4.98 Million - $6.11 Million
11,148 Added 8.19%
147,320 $69.7 Million
Q4 2020

Feb 10, 2021

BUY
$478.3 - $607.98 $2.77 Million - $3.52 Million
5,787 Added 4.44%
136,172 $65.8 Million
Q3 2020

Nov 13, 2020

SELL
$544.75 - $658.21 $1.41 Million - $1.7 Million
-2,586 Reduced 1.94%
130,385 $73 Million
Q2 2020

Aug 12, 2020

SELL
$493.32 - $643.92 $16 Million - $20.9 Million
-32,527 Reduced 19.65%
132,971 $82.9 Million
Q1 2020

May 14, 2020

BUY
$336.18 - $494.43 $13.9 Million - $20.4 Million
41,269 Added 33.22%
165,498 $80.8 Million
Q4 2019

Feb 12, 2020

BUY
$274.13 - $376.51 $5.98 Million - $8.21 Million
21,802 Added 21.29%
124,229 $46.6 Million
Q3 2019

Nov 12, 2019

BUY
$273.46 - $318.39 $820,106 - $954,851
2,999 Added 3.02%
102,427 $28.4 Million
Q2 2019

Aug 09, 2019

BUY
$299.6 - $414.82 $11.6 Million - $16 Million
38,672 Added 63.65%
99,428 $31.1 Million
Q1 2019

May 15, 2019

BUY
$372.08 - $439.57 $19.6 Million - $23.2 Million
52,675 Added 651.84%
60,756 $24.9 Million
Q4 2018

Feb 14, 2019

SELL
$335.82 - $403.04 $32.9 Million - $39.5 Million
-97,994 Reduced 92.38%
8,081 $3.02 Million
Q3 2018

Nov 13, 2018

BUY
$351.14 - $408.51 $3.33 Million - $3.87 Million
9,481 Added 9.82%
106,075 $42.9 Million
Q2 2018

Aug 14, 2018

SELL
$284.6 - $344.99 $234,225 - $283,926
-823 Reduced 0.84%
96,594 $33.3 Million
Q1 2018

May 15, 2018

BUY
$315.82 - $393.78 $13.5 Million - $16.8 Million
42,662 Added 77.91%
97,417 $33.5 Million
Q4 2017

Feb 14, 2018

SELL
$358.63 - $469.95 $4.63 Million - $6.07 Million
-12,922 Reduced 19.09%
54,755 $20.6 Million
Q3 2017

Nov 14, 2017

BUY
$431.38 - $504.0 $29.2 Million - $34.1 Million
67,677
67,677 $30.3 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $83.9B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.